Anita S. Chong to CTLA-4 Antigen
This is a "connection" page, showing publications Anita S. Chong has written about CTLA-4 Antigen.
Connection Strength
1.610
-
Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
Score: 0.541
-
Transplantation: molecular phenotyping of T-cell-mediated rejection. Nat Rev Nephrol. 2014 12; 10(12):678-80.
Score: 0.490
-
Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig. Am J Transplant. 2013 Sep; 13(9):2280-92.
Score: 0.448
-
CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Am J Transplant. 2002 Jan; 2(1):41-7.
Score: 0.050
-
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. Transplant Proc. 2000 Aug; 32(5):1003-4.
Score: 0.046
-
Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
Score: 0.015
-
Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc. 1998 Mar; 30(2):589.
Score: 0.010
-
Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation. 1997 Jul 27; 64(2):317-21.
Score: 0.009